EXICURE, INC.
🏢 View company profile →9Patents
9Active
9Granted
47Portfolio score
Filing activity: Jul 25, 2014 → Sep 3, 2020
Most-cited patents
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US10208310B2 | Anti-TNF compounds | Chemistry; Metallurgy | 16 | Active |
| US10182988B2 | Liposomal particles, methods of making same and uses thereof | Chemistry; Metallurgy | 16 | Active |
| US10792251B2 | Liposomal particles, methods of making same and uses thereof | Chemistry; Metallurgy | 11 | Active |
| US10434064B2 | Multivalent delivery of immune modulators by liposomal spherical nucleic acids for prophylactic or therapeutic applications | Human Necessities | 9 | Active |
| US10837018B2 | Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use | Emerging Cross-Sectional Technologies | 6 | Active |
| US10760080B2 | Anti-TNF compounds | Chemistry; Metallurgy | 5 | Active |
| US10894963B2 | Spherical nucleic acid-based constructs as immunostimulatory agents for prophylactic and therapeutic use | Emerging Cross-Sectional Technologies | 5 | Active |
| US10704043B2 | Nucleic acid nanostructures with core motifs | Chemistry; Metallurgy | 5 | Active |
| US11883535B2 | Liposomal particles, methods of making same and uses thereof | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Counts and citation impact are objective bibliographic measures.